A $3 Million Gene-Therapy Maker at a Bargain Price
Wall Street Journal
Sarepta’s treatment for Duchenne muscular dystrophy should become a blockbuster next year.
https://www.wsj.com/articles/a-3-million-gene-therapy-maker-at-a-bargain-price-1ce508bd